Skip to main content

Table 2 Payments by top 10 companies making the largest payments to allergists between 2016 and 2020

From: Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan

Ranking

Company name

Amounts of payments (%), $

Number of payments (%), No.

Number of allergists receiving payments (%), n

1st

AstraZeneca

6,056,278 (14.0)

2839 (9.2)

884 (22.4)

2nd

Boehringer Ingelheim Japan

4,071,844 (9.4)

2139 (6.9)

717 (18.2)

3rd

Novartis Pharma

3,205,803 (7.4)

1919 (6.2)

799 (20.3)

4th

Kyorin Pharmaceutical

2,585,524 (6.0)

2241 (7.3)

994 (25.2)

5th

Mitsubishi Tanabe Pharma

2,434,910 (5.6)

1354(4.4)

589 (14.9)

6th

Taiho Pharmaceutical

2,044,290 (4.7)

1491 (4.8)

623 (15.8)

7th

Sanofi

2,038,459 (4.7)

1292 (4.2)

599 (15.2)

8th

GlaxoSmithKline

2,026,210 (4.7)

1012 (3.3)

516 (13.1)

9th

Torii Pharmaceutical

1,841,077 (4.2)

1222 (4.0)

500 (12.7)

10th

Maruho

1,706,618 (3.9)

1037 (3.4)

409 (10.4)

  1. Legend: The ranking was based on the monetary amounts of non-research payments between 2016 and 2020